Summary The Chronic Kidney Disease (CKD) Drugs market research report provides the newest industry data and industry future trends, allowing you to identify the products and end users driving Revenue growth and profitability. The industry report lists the leading competitors and provides the insights strategic industry Analysis of the key factors influencing the market. The report includes the forecasts, Analysis and discussion of important industry trends, market size, market share estimates and profiles of the leading industry Players. Global Chronic Kidney Disease (CKD) Drugs Market: Product Segment Analysis Hyperphosphatemia: Dietary phosphate binders and dietary phosphate restriction Hypocalcemia: Calcium supplements and possibly calcitriol Hyperparathyroidism: Calcitriol or vitamin D analogues Anemia: Iron replacement therapy and erythropoiesis-stimulating agents Global Chronic Kidney Disease (CKD) Drugs Market: Application Segment Analysis Hospital use Clinic use Household Global Chronic Kidney Disease (CKD) Drugs Market: Regional Segment Analysis USA Europe Japan China India South East Asia The Players mentioned in our report Johnson & Johnson Abbott Laboratories F. Hoffmann-La Roche Takeda Pharmaceuticals Actavis Akebia Therapeutic Raptor Pharmaceuticals Rockwell Medical AMAG Pharmaceuticals Sanofi Reata Pharmaceuticals Cara Therapeutics FibroGen
Table of Content Chapter 1 About the Chronic Kidney Disease (CKD) Drugs Industry 1.1 Industry Definition and Types 1.1.1 Hyperphosphatemia: Dietary phosphate binders and dietary phosphate restriction 1.1.2 Hypocalcemia: Calcium supplements and possibly calcitriol 1.1.3 Hyperparathyroidism: Calcitriol or vitamin D analogues 1.1.1.4 Anemia: Iron replacement therapy and erythropoiesis-stimulating a
